Breaking News
Paying with gold in Venezuela. How it works
US, Argentina sign reciprocal trade and investment agreement
Argentina and the United States are finalizing preparations for "Atlantic Dagger"...
Multimaterial 3D printer builds fully functional electric motor from scratch in hours
Top Tech News
New Spray-on Powder Instantly Seals Life-Threatening Wounds in Battle or During Disasters
AI-enhanced stethoscope excels at listening to our hearts
Flame-treated sunscreen keeps the zinc but cuts the smeary white look
Display hub adds three more screens powered through single USB port
We Finally Know How Fast The Tesla Semi Will Charge: Very, Very Fast
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
When Placebos are Not Inert
Remember all the times I've said that efficacy trials for vaccines should not allow one vaccine to serve as the comparator of another vaccine?
That happened this week when the FDA sent Moderna a refusal-to-file letter, arguing that the application was not reviewable because Moderna used a standard flu dose as the comparator.
https://drtenpenny.substack.com/p/when-placebos-are-not-inert
Sadly, the FDA folded in 7 days, agreeing to an amended filing by Moderna, so FDA will review the new mRNA vaccine. No way this could be remedied in 7 days.
https://endpoints.news/fda-reverses-course-will-review-modernas-flu-vaccine/